The invention discloses a secondary separation method of Eptazocine midbody (plus/minus)-1-(2-Methylaminoethyl)-1-methyl-7-methoxyl group-1, 2, 3, 4-tetranap. The secondary separation method comprises the separation of L-tartaric acid, the pH value adjustment through concentration, extraction,...